Physician profile
Chandler R Mann
NPI 1629069190
$12,189.41
in general payments reported to CMS, 2019-2025
19 companies · $624 in 2025
The $624 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,140 · 2020: $289 · 2021: $586 · 2022: $637 · 2023: $4,170 · 2024: $1,743 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,750 · Food and Beverage: $2,787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,750.00 |
| Food and Beverage | $2,787.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,664.28 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Teva Pharmaceuticals USA, INC. | $3,750.00 | 2023 | |
| Medtronic, INC. | $2,009.43 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $884.01 | 2019-2025 | Proclaim, Eterna |
| Allergan, INC. | $249.97 | 2020-2021 | |
| Mml US, INC. | $139.35 | 2024 | Reactiv8 |
| Relievant Medsystems, INC. | $80.11 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $70.18 | 2025 | |
| Si-Bone, INC. | $45.30 | 2020 | |
| Nevro Corp. | $44.44 | 2020-2022 | |
| Painteq LLC | $43.03 | 2024 | Painteq |
| Pfizer INC. | $41.85 | 2019-2021 | |
| Medtronic USA, INC. | $41.25 | 2020 | |
| Saluda Medical Americas, INC. | $33.00 | 2023 | Evoke Scs |
| Almatica Pharma LLC | $27.87 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $27.66 | 2024 | Nalu Neurostimulation System |
| Assertio Therapeutics, INC. | $18.48 | 2020 | |
| Stimwave Technologies Incorporated | $16.16 | 2019 | |
| Epimed International, INC | $3.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandler Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.